
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
EU waters down plans to end new petrol and diesel car sales by 2035 - 2
New Cheetos and Doritos will be free of artificial dyes - 3
The most effective method to Plan an Incineration Administration: A Bit by bit Guide. - 4
NASA to bring astronauts home from space station early due to a medical issue - 5
James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
The Fate of Rest: Patterns in Shrewd Beds
Vote In favor of Your Favored Kind Of Cheddar
How does Spotify Wrapped calculate your listening age? What your number says about you.
4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
Beating Wellbeing Difficulties: Individual Victories in Health











